首页> 外文OA文献 >Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study

【2h】

Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study

机译：蛋白酶素，一种抗白细胞介素-36受体抗体，伴有棕榈术脓疱病的患者：IIA的结果，多中心，双盲，随机，安慰剂控制的试验研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ulrich Mrowietz; A. David Burden; Andreas Pinter; Kristian Reich; Knut Schäkel; Patrick Baum; Yakov Datsenko; Hongjie Deng; Steven J. Padula; Christian Thoma; Robert Bissonnette;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study [J] . Ulrich Mrowietz, A. David Burden, Andreas Pinter, Dermatology and Therapy . 2021,第2期

机译：Spesolimab，抗白细胞介素-36受体抗体，伴有棕榈术脓疱病的患者：IIA期，多中心，双盲，随机，安慰剂控制试验研究的结果
2. Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double-blind, placebo-controlled trial [J] . Umezawa Yoshinori, Nakagawa Hidemi, Tamaki Kunihiko The Journal of dermatology . 2016,第3期

机译：掌plant脓疱病患者马沙骨化醇软膏的三期临床研究：一项随机，双盲，安慰剂对照试验
3. Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patients. [J] . Horie Y, Kanada S, Watada H, Clinical therapeutics . 2011,第7期

机译：二肽基肽酶-4抑制剂利格列汀的药代动力学，药效学和耐受性概况：在日本2型糖尿病患者中进行的为期4周的多中心，随机，双盲，安慰剂对照IIa期研究。
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Efficacy and safety of trimodulin a novel polyclonal antibody preparation in patients with severe community-acquired pneumonia: a randomized placebo-controlled double-blind multicenter phase II trial (CIGMA study) [O] . Tobias Welte, R. Phillip Dellinger, Henning Ebelt, -1

机译：新型多克隆抗体制剂三调节蛋白在重症社区获得性肺炎患者中的有效性和安全性：一项随机安慰剂对照双盲多中心II期试验（CIGMA研究）
7. Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double-blind, placebo-controlled trial [O] . Yoshinori Umezawa, Hidemi Nakagawa, Kunihiko Tamaki 2015

机译：Mavoplantar诱发患者Maxacalcitol软膏的第III期临床研究：随机，双盲，安慰剂对照试验

Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study

著录项

引文网络

相似文献

相关主题

期刊订阅